Company intelligence / Profile preview

Sorcero

Washington, DC, United States

Ownership: Private
Development stage: Other

Overview

Sorcero develops an AI-driven analytics platform that enables life sciences companies to interpret complex, unstructured medical and real-world data, providing actionable insights for drug development, regulatory affairs, safety surveillance, market intelligence, and medical communications, validated by six foundational medical AI patents and recognized by numerous innovation awards.

Industry: Drug Discovery Services

Partnerships

Google Cloudalliances with 4 of top 5 pharma/biotech firms

Beyond the preview

Go deeper on Sorcero.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorcero.

Explore the full profile